Research articlePublished 14 Aug 2023

Development and Characterization of Neutralizing Antibodies against SARS-CoV-2

Authors: Yao Zhang, Ling Li, Yakun Li, Zengmin Yang, Aijing Zhang, Ercui Shen, Yun Liu, Yan Wang, Minghui Zheng, Xiao Chen, Shuming Wu, Haijiang Zhang, Yongjiang Liu

Immunotherapy: Open Access

Volume 9 · Issue 3 · Pages 1–7

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

Background: The novel coronavirus disease 2019 (COVID-19) caused by SARS-CoV-2 that belongs to betacoronaviruseis, and is an enveloped, single and positive-stranded RNA virus. In this study, we describe the production and characterization of four monoclonal antibodies with neutralization activities. Methods: Thirteen monoclonal antibodies that identified positive were characterized by neutralization assays, binding affinities identification, and the indirect sandwich Enzyme-Linked Immunosorbent Assay (ELISA) to evaluate the immunocompetence. The genes of neutralizing antibodies were sequenced and analyzed. Results: All monoclonal antibodies recognized two different epitopes respectively, including the receptor binding domain and human fragment crystallizable, and the binding affinities are also different. Four of nine monoclonal antibodies that can recognize the epitopes of the receptor binding domain are conformation neutralizing antibodies that have high binding affinity and neutralization ability. Based on the results sequencing, the monoclonal antibodies are unique antibodies with specificity. Conclusion: We characterized thirteen monoclonal antibodies, four of which are neutralizing antibodies and identified unique antibodies with specificity. The results highlight the promise of antibody-based therapeutics and provide the structural basis of rational vaccine design.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Longdom does not store it.

Try:

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalImmunotherapy: Open Access
  • SubjectImmunology & Microbiology
  • BylineArticles whose byline prints “Yao Zhang”
  • BylineArticles whose byline prints “Ling Li”
  • BylineArticles whose byline prints “Yakun Li”
  • BylineArticles whose byline prints “Zengmin Yang”
  • BylineArticles whose byline prints “Aijing Zhang”
  • BylineArticles whose byline prints “Ercui Shen”
  • BylineArticles whose byline prints “Yun Liu”
  • BylineArticles whose byline prints “Yan Wang”